The hOGG1 gene encodes a DNA glycosylase that excises 8-hydroxyguanine (oh Gua. Two isoforms of hOGG1 transcripts produced by alternative splicing encoded distinct hOGG1 proteins: one with and the other without a putative nuclear localization signal. Loss of heterozygosity at the hOGG1 locus was frequently (15/ 23, 62.2%) detected in lung cancer cells, and a cell line NCI-H526 had a mutation leading to the formation of the transcripts encoding a truncated hOGG1 protein. However, the oh 8 Gua levels in nuclear DNA were similar among lung cancer cells and leukocytes irrespective of the type of hOGG1 proteins expressed. These results suggest that the oh 8 Gua levels are maintained at a steady level, even though multiple hOGG1 proteins are produced due to genetic polymorphisms, mutations and alternative splicing of the hOGG1 gene.
Introduction

8-hydroxyguanine (oh 8
Gua), a major form of oxidative DNA damage induced by reactive free radicals, is highly mutagenic in vitro and in vivo (Kasai and Nishimura, 1991; Grollman and Moriya, 1993) . The presence of oh 8 Gua in DNA causes G:C to T:A transversion, since oh 8 Gua directs the incorporation of cytosine and adenine nucleotides opposite the lesion. To prevent the mutagenic eect of oh 8 Gua, three DNA repair enzymes (MutM, MutY and MutT proteins) exist in Escherichia coli (E. coli) (Tchou et al., 1991; Boiteux et al., 1992; Au et al., 1989; Michaels et al., 1991 Maki and Sekiguchi, 1992) . Recently, the OGG1 gene of Saccharomyces cerevisiae (yOGG1) was cloned as being a functional yeast homologue of the bacterial mutM gene (van der Nash et al., 1996) . Subsequently, a human homologue of the yeast OGG1 gene, hOGG1, was isolated based on the homology search of expressed sequence tags (Aburatani et al., 1997; Arai et al., 1997; Lu et al., 1997; Radicella et al., 1997; Roldan-Arjona et al., 1997; Rosenquist et al., 1997) . Since hOGG1 proteins eciently released the oh 8 Gua opposite the pyrimidine from DNA and cleaved the AP site in the same manner as yOGG1 protein, it was concluded that hOGG1 is a functional human homologue of the yOGG1 gene (Aburatani et al., 1997; Lu et al., 1997; Radicella et al., 1997; RoldanArjona et al., 1997; Rosenquist et al., 1997; Shinmura et al., 1997) .
Genetic backgrounds in control of the repair of damaged DNA have been shown to be involved in the susceptibility to cancer development (reviewed in Perera, 1996) . Therefore, it is worth investigating genetic polymorphisms of the hOGG1 gene, since a population with decreased enzyme activity of the hOGG1 gene would be at high risk of developing cancer in life because of an incomplete repair of oxidative DNA damage. The hOGG1 gene has been mapped to chromosome 3p26.2 (Arai et al., 1997) , a region showing loss of heterozygosity (LOH) in a variety of human cancers (Yokota and Sugimura, 1993; Gazder 1994) . In particular, 3p25-p26 is a common region of LOH in lung cancer (Hibi et al., 1992 , Hosoe et al., 1994 , and G:C to T:A transversions in the p53 gene occur frequently in lung cancer (Greenblatt et al., 1994) . Therefore, it is possible that the hOGG1 gene functions as a tumor suppressor (Lu et al., 1997) . In addition, previous Northern blot hybridization analysis of the hOGG1 gene indicated that alternative splicing of the hOGG1 gene occurs in human cells (Arai et al., 1997) . Thus, major forms of the hOGG1 transcripts should be elucidated for further functional analysis of the hOGG1 gene products.
In this report, we performed structural analysis of the hOGG1 gene and its transcripts in normal and cancerous cells of the lung. Our data indicated that, due to genetic polymorphisms and alternative splicing of the hOGG1 gene, multiple isoforms of hOGG1 protein are produced in human lung cells. We also found frequent LOH at the hOGG1 locus in primary lung tumors and an intragenic mutation of the hOGG1 gene in a lung cancer cell line. However, the oh Therefore, enzyme activities of the hOGG1 proteins may be high enough to maintain the oh 8 Gua levels at a steady level in human cells.
Results
Genetic polymorphisms of the hOGG1 gene
Genomic organization of the hOGG1 gene was determined by sequencing of a lambda phage clone and three bacterial arti®cial chromosome (BAC) clones covering the hOGG1 gene locus. The hOGG1 gene consisted of 7 exons and 6 introns, and the initiator ATG and terminator TAG sequences were located in the ®rst and seventh exons, respectively. This data was consistent with the one determined by Aburatani et al., (1997) .
Then, we searched for polymorphisms of the hOGG1 gene using genomic DNAs prepared from noncancerous lung tissues of 45 unrelated patients with lung cancer. Six pairs of intron based primers were used to amplify exons 1 ± 7 for the PCR-single strand conformation polymorphism (SSCP) analysis. By the direct sequencing of DNA fragments corresponding to shifted bands, ®ve dierent types of DNA polymorphisms were identi®ed (Table 1) . A C/G polymorphism at position 1245 in exon 7 was associated with an exchange of an amino acid, serine/cysteine, in codon 326. A silent polymorphism was found at codon 98 in exon 2, while three others were present in the noncoding region of the hOGG1 gene. Allele frequencies of these polymorphisms are shown in Table 1 .
Genetic alterations at the hOGG1 locus in lung cancer
We next undertook PCR ± SSCP analysis against 45 primary lung tumors. Somatic mutation of the hOGG1 gene was assessed by comparing the electrophoretic patterns of DNAs from 45 primary lung tumors with those from corresponding normal lung tissues. However, mutations of the hOGG1 gene were not detected in these materials.
Six, one, 19 and 19 of the 45 individuals were heterozygous for the polymorphisms at the 5'-noncoding region, codon 98, codon 326, and intron 4, respectively, and in total 23 of the 45 (51.1%) individuals were heterozygotes for the polymorphisms of the hOGG1 gene. Therefore, we could assess LOH at the hOGG1 locus in these cases. LOH was detected in 15 of the 23 cases (65.2%). Of the 19 cases heterozygous for the polymorphism at codon 326, four cases lost the hOGG1-Ser 326 allele and nine cases lost the hOGG1-Cys 326 allele. PCR ± SSCP analysis was also performed in 52 lung cancer cell lines. A G to A transition at the last nucleotide of exon 1 was detected in a lung cancer cell line, NCI ± H526 (Table 1 ). Arginine at codon 46 was replaced by glutamine by this transition. Direct sequencing of the PCR products covering exon 1 from NCI ± H526 cells revealed that NCI ± H526 was homozygous for the variant allele. Since the corresponding normal tissue DNA for this cell line was not available, we could not determine whether it was a rare genetic polymorphism or a somatic mutation.
Analyses of the hOGG1 transcripts hOGG1 transcripts were analysed by RT ± PCR using a set of primers which are located at the 5'-and 3'-non-coding regions, respectively. Multiple sizes of RT ± PCR products including two major forms were ampli®ed from human lung cancer cells and normal lung cells, and the ratio of the transcripts varied among cells (Figure 1a) . The relationship between the types of polymorphisms and the pattern of transcripts was not observed. We cloned two major forms of transcripts and determined the nucleotide sequences. The larger one was an alternatively spliced form containing 244 bp of the intron 6 sequence, while the smaller one was the same as the one we and others previously isolated (Arai et al., 1997; Lu et al., 1997; Radicella et al., 1997; Rosenquist et al., 1997) . Southern blot hybridization analysis using oligonucleotides derived from the intron 6 sequence as a probe con®rmed this result (Figure 1a) . In amino acid sequence encoded by the larger transcripts, 29 amino acids at the C-terminal were replaced by other eight amino acids, and a putative nuclear localization signal (NLS) was lacked as reported by Aburatani et al., (1997) .
Notably, two other distinct transcripts were detected as major ones in NCI ± H526 cells in addition to the two forms of transcripts described above. We cloned these transcripts and determined the nucleotide sequences. These transcripts contained the 521 bp intron 1 sequence, resulting in a premature termination just after exon 1. Southern blot hybridization analysis using oligonucleotides derived from the intron 1 sequence as a probe con®rmed this result (Figure 1a ). This result indicated that NCI ± H526 cells expressed truncated hOGG1 proteins in addition to two fulllength isoforms of hOGG1 proteins with and without NLS. We also examined the hOGG1 transcripts in lung cancer cell lines by Northern blot hybridization analysis ( Figure 1b) . Again, the relationship between the types of polymorphisms and the pattern of the transcripts was not observed, except that the size of the hOGG1 transcripts in NCI ± H526 cells was approximately 0.5 kb greater than those in other cell lines. Gua in DNA and has an extremely high G:C to T:A mutation rate (Arai et al., 1997; Suzuki et al., 1997) (Table 2 ). The number of Rif R colonies was reduced by either of three types of GST-hOGG1 fusion proteins. However, it is noted that the degrees of suppression by the hOGG1-Cys 326 and hOGG1-Gln 46 proteins were signi®cantly smaller than that by the hOGG1-Ser 326 protein.
Genotypic and allelic frequency of the polymorphism at codon 326 in healthy individuals and lung cancer patients Gua DNA repair prompted us to examine the association of the Cys 326 allele with the susceptibility to human lung cancer. We undertook a comparative analysis of the distribution of the genotypes and the allele frequencies of the polymorphism at codon 326 between 42 healthy individuals and 45 lung cancer patients (Table 3) . In both groups, the distribution of the polymorphic alleles Gua DNA repair diers among human cells due to the polymorphic genotype in this region of the hOGG1 gene.
In this study, crude comparison of the distribution of the polymorphism at codon 326 did not detect the dierence between healthy individuals and lung cancer patients, but obviously, confounding factors such as age and smoking dosage should be incorporated to the interpretation. A larger case-control study is in progress. Furthermore, the other four genetic polymorphisms of the hOGG1 gene were not examined in detail in this study. It is possible that those polymorphisms are associated with the dierences in cellular enzyme activity by changing mRNA stability, eciency in transcription and translation. Therefore, comparative analysis of the multiple polymorphisms at the hOGG1 locus among a large number of healthy individuals and patients with a variety of cancers should be done to assess the involvement of the hOGG1 gene in human carcinogenesis.
Multiple alternative splicing isoforms of the hOGG1 gene, including two major isoforms, were detected in both normal lung cells and lung cancer cell lines. This is consistent with the previous result that multiple sizes of mRNA transcripts were detected in human organs and lung cancer cell lines (Arai et al., 1997) . One of major form hOGG1 transcripts encoded a protein with a nuclear localization signal (NLS) that was translated from the transcripts composed of exons 1 ± 7, while the other was an isoform lacking NLS translated from the transcripts with intron 6. Aburatani et al. (1997) reported another isoform lacking NLS, in which exon 7 was replaced by exon 8 located at the downstream of exon 7. hOGG1 proteins without NLS are expected to have dierent intracellular localization. Recently, hMTH protein, a 8-hydroxydeoxyguanosine triphosphatase, was shown as being present in nucleus, mitochondria and cytosol (Kang et al., 1995) . Therefore, each isoform of the hOGG1 proteins may have distinct intracellular localization and distinct functions in human cells. It is also possible that some isoforms are involved in the regulation of the enzyme activity of the major isoform of hOGG1 protein.
The hOGG1 gene is located at chromosome 3p26.2 (Arai et al., 1997), a commonly deleted region in lung cancer cells (Hibi et al., 1992 , Hosoe et al., 1994 . Since the VHL tumor suppressor gene at 3p25 is not altered in human lung cancer cells, a target gene at this chromosomal region is still unidenti®ed (Sekido et al., 1994) . Thus, we examined whether the hOGG1 gene is frequently altered in lung cancer cells. LOH at the hOGG1 locus was frequent, while intragenic mutation of the hOGG1 gene was infrequent in human lung cancer cells. Therefore, it is unlikely that the hOGG1 gene is commonly inactivated by chromosomal Gua in DNA and it may accelerate the acquisition of G:C to T:A mutations.
A nucleotide change was detected at the last nucleotide of exon 1 in NCI ± H526 cells. This nucleotide change causes the conversion of an amino acid at codon 46, which is located in a domain highly conserved in the yeast counterpart (Arai et al., 1997) . Activity to suppress spontaneous mutagenesis of hOGG1-Gln 46 protein in an E. coli strain was weaker than those of hOGG1-Ser 326 and hOGG1-Cys 326 proteins. Furthermore, this nucleotide change caused abnormal splicing of the hOGG1 gene. Due to a partial inactivation of the 5' splice site of intron 1, readthrough transcripts of intron 1 encoding a truncated hOGG1 protein were produced in NCI ± H526 cells. This result is compatible with the previous report that base changes at the terminal nucleotide position of exons lead to the abnormal splicing of the genes (Huang et al., 1993; Garuti et al., 1996) . Guanine at the last nucleotide of exon resides in the consensus sequence at the 5' splice site, which is recognized and bound by U1 small nuclear RNA in the 5' splice site selection (Chabot, 1996) . Therefore, G to A change at this site could weaken the splicing signal, allowing the maturation of both full-length and readthrough transcripts from primary transcripts in NCI ± H526 cells. Interestingly, this nucleotide change was not detected in 45 normal DNAs. Therefore, this variant can be a somatic mutation and not a genetic polymorphism, although this cannot be concluded because of the lack about the sequence in information of the normal DNA corresponding to the cell line.
We demonstrated that multiple isoforms of hOGG1 protein are produced in human cells due to polymorphisms, mutations and alternative splicing of the hOGG1 gene. The result of structural and functional analysis in this study suggested the presence of dierence in the enzymatic activity and property among hOGG1 isoforms. We preliminarily compared oh 8 Gua DNA glycosylase and AP-lyase activities, which are known as two major enzyme activities of hOGG1 protein , among puri®ed GST-hOGG1-Ser 326 , GST-hOGG1-Cys 326 and GST-hOGG1-Gln 46 proteins. However, their activities were not signi®cantly dierent among the three isoforms. Therefore, the enzyme activities, which account for the dierence in ability to suppress spontaneous mutagenesis of a E. coli mutant defective in the repair of oh 8 Gua, have not been elucidated. Other factors including stability of the proteins or interaction with other proteins involved in the repair process may be signi®cant for the dierence. In contrast to the fact that multiple isoforms of hOGG1 protein are produced in human cells, the oh 8 Gua levels in nuclear DNA were similar among lung cancer cell lines and peripheral leukocytes irrespective to the type of hOGG1 proteins expressed. Thus, it is possible that intracellular activities of hOGG1 proteins may be high enough to maintain the oh 8 Gua contents at a steady level in nuclear DNA under conditions without severe oxidative stress. Intercellular variation of the oh 8 Gua levels may become distinct, only when formation of oh 8 Gua is highly induced by reactive oxygen species. Therefore, it would be important to analyse the oh 8 Gua levels under conditions with high oxidative stress to elucidate whether each isoform of hOGG1 proteins have enough activities. Alternatively, it is also possible that other proteins than hOGG1 play more signi®cant roles in the repair of oh 8 Gua in human cells. This idea is supported by the previous result that human cell extract includes repair enzymes for oh 8 Gua, whose enzymatic property is dierent from that of hOGG1 protein (Bessho et al., 1993) . We have to also consider the possibility that intercellular variation of the oh 8 Gua levels was masked due to contamination of arti®cially produced oh 8 Gua during preparation of deoxynucleoside samples. Although the oh 8 Gua contents measured by our method is much lower than those by other methods (Malins et al., 1991; Asami et al., 1996; Nakajima et al., 1996) , we can not completely exclude the possibility that a signi®cant portion of the oh 8 Gua detected in this study was produced arti®cially during preparation.
Recently, we have demonstrated the presence of the considerable interindividual variations (7.2-fold) in the oh 8 Gua levels among the leukocytes of healthy individuals (Asami et al., 1996) . The result of this paper indicated that the intervariations in the oh 8 Gua levels were not directly correlated with the genetic polymorphisms of the hOGG1 gene. Life-style, age, sex, environment and genetic dierences other than hOGG1 may have more signi®cant eects on the level of oh 8 Gua in human cells. However, it is possible that interindividual dierence in capacity and property for the repair of oh 8 Gua is associated with the type of hOGG1 proteins expressed. A population with reduced capacity can be at high risk of developing cancer due to incomplete repair of oh 8 Gua, especially when the formation of oh 8 Gua is increased by exposure to mutagen, carcinogen and g-ray irradiation. Therefore, functional analysis of the multiple isoforms of hOGG1 proteins in vivo as well as in vitro should be done in more detail to assess whether each of multiple forms of hOGG1 protein has distinct activities in the repair of oh 8 Gua in damaged DNA.
Materials and methods
Samples
Thirty-three NSCLC cell lines (A427, A549, Lu65, Lu99, NCI ± H23, NCI ± H157, NCI ± H322, NCI ± H441, NCI ± H520, NCI ± 596, NCI ± H1155, PC3, PC7, PC9, PC10, PC13, Ma1, Ma2, Ma3, Ma10, Ma12, Ma17, Ma24, Ma25, Ma26, Ma29, Ma31, LC1-Sq, RERF ± LCD, RERF ± LCOK, RERF ± LCMS, ABC1 and EBC1) and 19 small cell lung carcinoma cell lines (NCI ± H69, NCI ± H82, NCI ± H209, NCI ± H526, NCI ± H774, NCI ± H841, N230, N231, N417, Lu24, Lu130, Lu134, Lu135, Lu138, Lu139, Lu140, Lu141, SBC-5 and MS18) were used in this study (Kohno et al., 1995) . Detailed information on these cell lines can be obtained upon request. High-molecular-weight DNA was prepared from tumors and adjacent noncancerous tissues of 45 patients with SCLC or NSCLC, and from peripheral blood samples of 42 unrelated healthy indivi-duals as described previously (Shiseki et al., 1994 (Shiseki et al., , 1996 Baba et al., 1995) . Poly(A) RNA was prepared by the Fast Track mRNA isolation kit (Invitrogen Corp.).
Determination of the exon-intron organization of the hOGG1 gene
High Density BAC Colony Membranes (Research Genetics) were screened with a 32 P-labeled hOGG1 cDNA probe according to the supplier's protocol. Three BAC clones, 168D44, 176M11 and 187A24 were positive for the probe and BAC DNAs for these clones were isolated according to the supplier's protocol. Phage DNA of G27 (Arai et al., 1997) and PCR products from BAC clones were used for DNA sequencing. Sequence analysis was performed along the exons, at the exon-intron boundaries, and at the 5'-and 3'-¯anking regions of the exons by f-mol DNA sequencing system (Promega) or using the 373S DNA sequencer with DNA sequencing kit (Applied Biosystems).
PCR ± SSCP and PCR ± LOH analyses
Exons 1 ± 7 of the hOGG1 gene were ampli®ed for SSCP analysis with six sets of PCR primers: 5'-TGAATTCGTCTTTGGGCGTCGACGA-3' and 5'-ACA-GGCTTCTCAGGCTCAGT-3' for exon 1, 5'-ATT-GAGTGCCAGGGTTGTCA-3' and 5'-TGGCAAAACT-GAGTCATAGAG-3' for exon 2, 5'-AACAGCAGGT-ACCTGTCCTA-3' and ACAGATCTTGAAAGCTGA-TGG for exon 3, 5'-GAGAGCTCACTTACTAGCCT-3' and 5'-AGTAGAGAGGGCAGCTCCTA-3' for exon 4, 5'-AAGCAAGATGCTGGCCACAT-3' and 5'-TGGTGGAA-GAGTCCACTGG-3' for exons 5 and 6, and 5'-ACTGT-CACTAGTCTCACCAG-3' and 5'-TGAATTCGGAAG-GTGCTTGGGGAAT-3' for exon 7. PCR ± LOH and PCR ± SSCP analyses were performed as described previously (Sameshima et al., 1992 . Brie¯y, PCR was carried out by using 50 ng genomic DNA as a template, in a 20 ml reaction mixture containing 0.25 m of [a7 32 P]dCTP (3000 Ci/mmol, 10 Ci/ml). After 35 cycles of 958C (60 s) for denaturation, 558C (60 s) for annealing, 728C (90 s) for extention, PCR products were denatured and electrophresed on neutral 5% polyacrylamide gel with and without 5% (vol/vol) glycerol. Gels were dried and exposed to X-ray ®lms at 7808C. DNA fragments corresponding to the band were reampli®ed by PCR. PCR products were puri®ed using a QIA quick-spin PCR puri®cation kit (QIAGEN Inc.), and directly sequenced with fmol DNA cycle sequencing system (Promega) or using the 373S DNA sequencer with DNA sequencing kit (Applied Biosystems). In PCR ± LOH analysis, the signal intensity of polymorphic alleles was quanti®ed and calculated by the scanning densitometer and data analysis system (The Discovery Series, Quantity One, pdi, New York). LOH was considered to be present if the radiographic signal of one allele was at least 50% reduced in the tumor DNA when compared to its corresponding normal allele.
RT ± PCR and Northern blot hybridization analyses of the hOGG1 gene Randomly primed cDNAs were reverse-transcribed from 0.5 mg of mRNAs using SuperScript II RNase H-Reverse Transcriptase (Gibco BRL) in a 20 ml mixture according to the supplier's protocol. One ml of the cDNA conversion mixture was ampli®ed by PCR in a 10 ml reaction mixture using a set of primers, 5'-TGAATTCGTCTTTGG-GCGTCGACGA-3' and 5'-TGAATTCGGAAGGTGC-TTGGGGAAT-3'. A hOGG1 cDNA clone (Arai et al., 1997) was also subjected to this analysis as a control. After 35 cycles of 958C (60 s) for denaturation, 528C (60 s) for annealing, 728C (90 s) for extention, PCR products were fractionated by 1.0% agarose gel electrophoresis, and were transferred to Hybond N-plus membranes (Amersham). Southern blot hybridization was performed with oligonucleotides probes (5'-ACAGGCTTCTCAGGCTCAGT-3' in inron 1, 5'-AAAGTCCTGCACACTGGA-3' in exon 2 and 5'-ACTGTCACTAGTCTCACCAG-3' in intron 6) labeled with polynucleotide kinase according to the standard procedure (Maniatis, 1982) . Northern blot hybridization analysis of the hOGG1 gene was performed as described previously (Arai et al., 1997) . Brie¯y, 3 mg of poly(A) RNA were fractionated in 1% denaturing formaldehyde/agarose gels and transferred to Hybond N-plus membranes (Amersham). The membrane was sequentially hybridized to the hOGG1 (nucleotide 554 ± 916 of hOGG1 cDNA) and b-actin cDNA probes according to the standard procedure (Maniatis 1982) . b-actin cDNA was used for standardizing the RNA amounts on the membrane.
Complementation of an E. coli (mutM mutY) mutant with hOGG1-overproducing plasmid Plasmids expressing GST-hOGG1-Ser 326 , GST-hOGG1-Cys 326 and GST-hOGG1-Gln 46 fusion proteins were constructed by PCR ampli®cation of hOGG1 cDNA (Arai et al., 1997) , cDNAs synthesized from mRNA of PC10 and NCI ± H526 cells using a set of primers, 5'-TGAATTCAT-GCCTGCCCGCGCGCTT-3' and 5'-TGAATTCCTAG-CCTTCCGGCCCTTT-3'. PCR products were inserted into the EcoRI site of pGEX ± 1lT (Pharmacia biotech), and nucleotide sequences were determined on both strands of the cloned inserts. Detailed protocol for the complementation assay was described previously (Arai et al., 1997) . Brie¯y, overnight cultures of YG5132 transformed with each hOGG1-overproducing plasmid and of control were analysed for rifampicin resistant mutation events. In each group, two plates were prepared, and average numbers of rifampicin resistant Rif R colonies per 10 8 cells were recorded. t-test was used for statistical analyses.
Quanti®cation of oh 8
Gua levels in lung cancer cell lines and peripheral leukocytes DNA Human peripheral blood samples were obtained from six healthy male volunteers, who were homozygous either for Cys or Ser at codon 326. They are never-smokers of 28 ± 33 years old, but no information was available on the history of passive smoking. Buy coat fractions of blood samples (20 ml) and lung cancer cell lines (3610 6 cells) were frozen until used for the determination of the amount of oh 8 Gua in DNA. Detailed protocol for the quanti®cation of oh 8 Gua levels in DNA was described previously (Asami et al., 1996) . Brie¯y, DNA was extracted using the DNA Extractor WB Kit (Wako junyaku, Tokyo, Japan), and digested with nuclease P1 and acid phosphatase in a 10 mM sodium acetate solution (378C for 30 min). After incubation, the mixture was treated with the ion exchange resin Muromac (Muromachi kagaku, Tokyo, Japan) and was centrifuged at 15 000 g for 5 min. The supernatant was ®ltrated by a ®lter tube (Millipore; Samprep C; 0.2 mm), and injected onto an high-performance liquid chromatography column (Beckman; Ultrasphere-ODS; 5 mm, 4.66250 nm) equipped with an electrochemical detector (ESA Coulochem II: detector 1, 0.15 V; detector 2, 0.30 V). As standard samples, 20 ml each of deoxyguanosine (0.5 mg/ml) and 8-hydroxydeoxyguanosine (5 ng/ml) solutions were injected. The value of oh 8 Gua was calculated as the number per 10 5 guanine.
